AI reads MRI scans to spot hidden sarcomas
NCT ID NCT06073314
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tested whether artificial intelligence (AI) can help doctors tell the difference between cancerous and non-cancerous soft tissue lumps using MRI scans. 186 patients with soft tissue masses had extra MRI images taken. The AI was trained to identify which lumps were sarcoma and how aggressive they were. The goal is to make diagnosis faster and more accurate without needing a biopsy every time.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SARCOMA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Leeds Teaching Hospitals
Leeds, United Kingdom
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a new protein drug shield kids with cancer from dangerous infections?
- Can two drugs together fight Hard-to-Treat bone and Soft-Tissue cancers?
- Can a new drug ST316 shrink Hard-to-Treat tumors?
- New PET tracer could sharpen sarcoma detection
- Protein-Wrapped chemo aims to hit tumors harder, spare healthy cells
- Hip muscle repair method may improve walking after bone cancer surgery